AI-generated summary
The authors retrospectively analyzed 31 patients with primary burning mouth syndrome treated with photobiomodulation between 2018 and 2021, measuring pain by numerical rating scale. They report immediate pain reduction, with median scores falling from 8 to 1, and a partial recurrence at 3 to 5 years, with median scores of 6 that remained below baseline. Responses varied among patients.
- Participants
- 31
- Who or what was studied
- Adults with primary burning mouth syndrome treated with photobiomodulation between 2018 and 2021
- Limits stated in the abstract
- The study is retrospective, lacks a control group, and the authors state that larger controlled studies are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.